A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas

HIF-1α stimulates the progression of oesophageal squamous cell carcinoma by activating the Wnt/β-catenin signalling pathway

(2022) Kang Tang et al.   BRITISH JOURNAL OF CANCER

Surgical Neuro-Oncology

(2022) Dana Mitchell et al.   NEUROLOGIC CLINICS

Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy

(2022) Xuemeng Li et al.   PHARMACOLOGICAL RESEARCH

Inhibition of translocator protein 18 kDa suppressed the progression of glioma via the ELAV-like RNA-binding protein 1/MAPK-activated protein kinase 3 axis

(2022) Jingya Wang et al.   Bioengineered

Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism

(2022) Abhilasha Sharma et al.   Frontiers in Genetics

The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma

(2021) Anshika Goenka et al.   Cells

oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data

(2021) Danielle Maeser et al.   BRIEFINGS IN BIOINFORMATICS

NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition

(2021) Cheng-Yu Tsai et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

SHOX2 cooperates with STAT3 to promote breast cancer metastasis through the transcriptional activation of WASF3

(2021) Yong Teng et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia

(2021) Xing-chen Ding et al.   Journal of Hematology & Oncology

Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer

(2021) Macus Hao-Ran Bao et al.   Cells

Hypoxia‐inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy

(2021) Kuo‐Hao Ho et al.   CANCER SCIENCE

HOXC6/8/10/13 predict poor prognosis and associate with immune infiltrations in glioblastoma

(2021) Mingjun Yu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing

(2021) Mingtao Ao et al.   JOURNAL OF NANOBIOTECHNOLOGY

A Hypoxia-Associated Prognostic Gene Signature Risk Model and Prognosis Predictors in Gliomas

(2021) Feng Gao et al.   Frontiers in Oncology

Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival

(2020) Chitra Joseph et al.   BREAST CANCER RESEARCH AND TREATMENT

Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma

(2020) Junhui Liu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas

(2020) Barbara Oldrini et al.   Nature Communications

Molecular landmarks of tumor hypoxia across cancer types

(2019) Vinayak Bhandari et al.   NATURE GENETICS

Seven genes for the prognostic prediction in patients with glioma

(2019) G.-H. Zhang et al.   Clinical & Translational Oncology

MyoD1 suppresses cell migration and invasion by inhibiting FUT4 transcription in human gastric cancer cells

(2019) Fei Wu et al.   CANCER GENE THERAPY

In vivo assessment of reactive oxygen species production and oxidative stress effects induced by chronic exposure to gamma radiation in Caenorhabditis elegans

(2019) Erica Maremonti et al.   FREE RADICAL BIOLOGY AND MEDICINE

Temozolomide for immunomodulation in the treatment of glioblastoma

(2018) Aida Karachi et al.   NEURO-ONCOLOGY

Overcoming therapeutic resistance in glioblastoma: the way forward

(2017) Satoru Osuka et al.   JOURNAL OF CLINICAL INVESTIGATION

MicroRNA-145 induces apoptosis of glioma cells by targeting BNIP3 and Notch signaling

(2017) Yan Du et al.   Oncotarget

Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment

(2016) Jun-Hai Tang et al.   EXPERIMENTAL CELL RESEARCH

Deletions of 5′HOXCgenes are associated with lower extremity malformations, including clubfoot and vertical talus

(2016) David M Alvarado et al.   JOURNAL OF MEDICAL GENETICS

Neuromuscular electrical stimulation improves radiation-induced fibrosis through Tgf-Β1/MyoD homeostasis in head and neck cancer

(2016) Grace Peng et al.   JOURNAL OF SURGICAL ONCOLOGY

SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II–III Diffuse Gliomas

(2016) Yu-An Zhang et al.   EBioMedicine

Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells

(2015) Lina Yang et al.   CANCER LETTERS

Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer

(2015) Christine Mehner et al.   Oncotarget

MGMT testing—the challenges for biomarker-based glioma treatment

(2014) Wolfgang Wick et al.   Nature Reviews Neurology

Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner

(2013) Panagiotis J. Vlachostergios et al.   INVESTIGATIONAL NEW DRUGS

Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications

(2012) Liuqi Yang et al.   EXPERIMENTAL CELL RESEARCH

SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma

(2011) Christoph Kneip et al.   Journal of Thoracic Oncology

Hypoxia Helps Glioma to Fight Therapy

(2009) Verena Amberger-Murphy   CURRENT CANCER DRUG TARGETS